Concepedia

Management of Extensively Drug-Resistant Tuberculosis in Peru: Cure Is Possible

César Antonio Bonilla-Asalde, Aldo Crossa, Hector O. Jave, Carole D. Mitnick, Ronal B. Jamanca, Cesar Herrera, Luis Asencios, Alberto Mendoza‐Ticona, Jaime Bayona, Matteo Zignol,

PLoS ONE · 2008 · 67 citations · 9 references

DOIFull text

Open access

Abstract

In the Peruvian context, with long experience in treating MDR-TB and low HIV burden, although the overall cure rate was poor, a large proportion of XDR-TB patients can be cured if DST to second-line drugs is performed early and treatment is delivered according to the WHO Guidelines.

References

9

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Neel R. Gandhi, Anthony P. Moll, A. Willem Sturm et al. · The Lancet · 2006 · 1.7K citations

, , +9

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

Dennis Falzon, E. Jaramillo, Holger J. Schünemann et al. · European Respiratory Journal · 2011 · 1.1K citations · Full text

, , +22

Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs--Worldwide, 2000-2004

PsycEXTRA Dataset · 2006 · 515 citations

, , +20

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Kayla F. Laserson, Lorna E. Thorpe, Vaira Leimane et al. · PubMed · 2005 · 293 citations

Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment Outcome

Timothy H. Holtz, Maya Sternberg, Steve Kammerer et al. · Annals of Internal Medicine · 2006 · 230 citations